bpc-157 cancer study Heal or Harm: Body Protective Compound-157 in the Gray Zone Therapeutic potential of pro-angiogenic BPC157
Description
In addition, concerning intestinal diseases, studies on functional foods mainly focus on macromolecules such as prebiotics and polysaccharides
Some peptides (notably GLP-1 receptor agonists like semaglutide and newer dual agonists such as tirzepatide) reduce appetite, slow gastric emptying, and improve blood sugar control- mechanisms that reliably produce weight loss in clinical trials
Therapies like BPC-157 may one day become supportive tools in this toolkit, but they must be considered experimental
Dietary Modifications Including more B12-rich foods in the daily diet is recommended, particularly for those with borderline deficiency
